Dr. Joseph S. Friedberg, Head of Thoracic Surgery at UMD

Joseph S. Friedberg M.D.

Chief of Thoracic Surgery

About Joseph S. Friedberg

When it comes to treating pleural mesothelioma, thoracic surgeon Dr. Joseph Friedberg sees a ray of light for patients suffering from the disease.

Get in touch

Accolades

Pleural and Lung Cancer icon

Pleural and Lung Cancer

Top Doctor icon

Top Doctor

Team Leader icon

Team Leader

Works for Specialty Center icon

Works for Specialty Center

Board Certified icon

Board Certified in Surgery

Board Certified icon

Board Certified in Thoracic and Cardiac Surgery

“We’re bringing all the modalities to bear in fighting this disease. We are slowly nudging mesothelioma towards being more of a chronic disease, not a lethal one…Most people think it’s untreatable…but we don’t believe that’s the case,” said Friedberg and colleagues in the wake of a surprising discovery, published in the June 2011 issue of Annals of Thoracic Surgery.

More About

Joseph S. Friedberg M.D.

Specialty

Chief of Thoracic Surgery

Medical Treatment Center

University of Maryland Greenebaum Cancer Center

Contact

Get in touch

Focus on Mesothelioma

Friedberg, Division Head of Thoracic Surgery at the University of Maryland School of Medicine, found that patients who underwent lung-sparing surgery in combination with photodynamic therapy showed superior overall survival rates than comparable patients who opted for the more traditional treatment of having an entire lung removed.

Quick Fact

Dr. Friedberg was on the team of researchers that worked to develop a lung cancer vaccine.

He previously was the chief of thoracic surgery and co-director of the Penn Mesothelioma and Pleural Diseases Program at the University of Pennsylvania Medical Center.

In hopes of developing treatments for advanced cancers and malignant mesothelioma, Friedberg has spearheaded several investigational trials. Included in those studies is research on the potential of a lung cancer vaccine.

Friedberg began seeing patients at the Greenebaum Cancer Center in late 2014, joining a multidisciplinary team of specialists . Together they review each case to develop a treatment plan specific to each patient.

Our primary motivation in attempting the lung-sparing surgery was preservation of quality of life. We were completely caught off guard when the analysis revealed a significantly longer survival for the patients who retained both lungs.

– Dr. Friedberg

Talk to a Doctor About Your Diagnosis

We can help you or a loved one get in contact with Dr. Friedberg and find the treatment that's best for you.

Get Started Today

Friedberg received his medical degree from Harvard Medical School and completed specialized training in thoracic surgery at Brigham and Women’s Hospital. He is board-certified in thoracic surgery and is considered an expert at video-thoracoscopic procedures for treatment of chest diseases. His research findings have been profiled in several professional journals, including Clinical Cancer Research and the Journal of Clinical Oncology.

Publications

Disclaimer: Dr. Joseph S. Friedberg has no professional affiliation with Asbestos.com.

  •  
  •  
  •  

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?


Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Last Modified March 1, 2018
Get Help Contacting Joseph S. Friedberg

View our resources for patients and families

Get Help Today
Get Your Free Mesothelioma Guide Chat live with a patient advocate now loading spinner